Fact CheckerSign in

NCT03973671Recruiting

Prospective Sample Collection for Cancer of Bladder

Flemish Prospective Clinical and Pathological Database for Urothelial Cancer

Source: ClinicalTrials.gov · Last updated 28 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of the Flemish Databank for Urothelial Cancer is to collect clinical and pathological data of patients treated for urothelial cancer (UC).

Status (registry)
Recruiting
Study type
Observational
Enrollment
300 (estimated)
First submitted
3 Jun 2019
Start date
29 May 2020
Primary completion date
31 May 2027
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
NCT number
NCT03973671

What you commit to

  • Study type: Observational
  • Planned participants: 300
  • From 29 May 2020 to the primary completion date, 31 May 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • patients who do not give their informed consent to collect their clinical and pathological data,
  • patients who withdraw their informed consent to use their clinical and pathological data,
  • patients who refuse the planned treatment,
  • women who are pregnant or have suspicion of pregnancy.

Who the study is looking for

  • who are aged between 18-90,
  • who are of male or female sex,
  • who give their informed consent to collect their clinical and pathological data,
  • who are planned to undergo TURBT for BC,
  • who are planned to undergo (salvage) radical cystectomy with or without an extended pelvic lymph node dissection,
  • who are planned to undergo tumor biopsy (from primary or metastatic tumor),
  • who are planned to undergo radical nephroureterectomy ± partial cystectomy or segmental ureterectomy, with or without a lymph node dissection,
  • who are planned to undergo endoscopic tumor biopsy or resection,
  • from whom metastases will be surgically removed.

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospitals Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.